Novamind

Novamind is focused on addressing the world’s mental health crisis through the integration of psychedelic-assisted psychotherapy into modern psychiatry. Early data collected from current U.S Food and Drug Administration clinical trials suggest that psychedelics will revolutionize the treatment of mental health disorders including: anxiety, depression, post-traumatic stress disorder and addiction.

Sovereign State worked with Novamind to integrate the qualities of the brand into an evolved identity - guidance, compassion and healing. A full brand guideline was developed to direct the implementation of the brand into its various environments and sub-brands.

Strategy
Identity
Brand Guidelines

Animation: Good Form Studio

Psychedelic Medicine

Henda quae consequas denand eaquiatin resedici quia ressi as madis diatae sedit

Ustia vel Novamind

Uptia cus molorum quia ius illoreni tovidut ipsae ommolupta cus esquam. Ehiciaepe arum ipsunt, od ut plique corem expliquat. Faccae sam, norsot repreratiost edolorem core, sioccu tinus et eaut molore mpos molorum dolores erspell estiant quisimits. Aximos ullaborit, cupta doloremquae quibus de plisqui vel tatest, quam hic to bla cum adigenis alibus, quia iur ra sun tionse et excestius de res dolupta tusciet il mostia velis peri corehenis moles rem qui di. Oluptati aeprepe ribus, inihicaes. Bus alibusanis ex experfem se rorrovi diciamre sam et ex et experepres sedipit aliti.